Literature DB >> 17765917

Validation of peptide epitope microarray experiments and extraction of quality data.

Tatjana Nahtman1, Alexander Jernberg, Shahnaz Mahdavifar, Johannes Zerweck, Mike Schutkowski, Markus Maeurer, Marie Reilly.   

Abstract

INTRODUCTION: Within the last decade, the development of antigen microarray slides has enabled the simultaneous measurement of serum reactivity to hundreds of peptides in a single biological sample. Despite this considerable scientific progress, many issues remain regarding the quality, analysis and interpretation of the data these slides produce. There is currently no accepted approach to guide data analysis, and researchers use a wide variety of statistical methods and software tools. We designed and implemented a laboratory experiment to assess the reliability and range of measurement of peptide microarray data, and present graphical and statistical procedures for pre-processing so that quality data can be extracted for addressing biological hypotheses.
METHODS: Synthetic peptides spanning the proteins Ag85A, Ag85B, CFP10, MPT51/MPB51, TB10.4 and ESAT-6 were chosen as a paradigm to screen for serum reactivity to Mycobacteria tuberculosis (MTB). We explored various quantitative and graphical methods for presenting the responses from a slide. We replicated assays of samples from five TB-positive individuals to examine reproducibility, and used linear mixed models to investigate the various sources of variability, and to assess the range of measurement. We use our methods to extract data from the five TB-positive individuals and five healthy controls, and analyse the "normalized" responses using the freely available SAM package.
RESULTS: The ratio of foreground to background signal (on a log scale) provides an appropriate response index. A two-dimensional graphical display clearly illustrates the responses from the control and peptide features on a slide. Mixed model analysis of the replicated slides found a high reproducibility of the assay between operators, days and experiments. The range of measurement was also satisfactory. Our analysis of the normalized responses from the five TB-positive patients and five healthy controls suggested that 10 of the 363 peptides assessed had significantly higher responses in the TB-positive group.
CONCLUSIONS: Carefully designed laboratory experiments and rigorous statistical analysis can enable the removal of technical artefacts to produce quality peptide array data for addressing biological hypotheses. These instruments, which enable valid comparisons across slides and/or batches of slides, will escort future comparative analyses targeting high content serum reactivity profiling against a broad array of B-cell epitopes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765917     DOI: 10.1016/j.jim.2007.07.015

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

Review 1.  Immunoinformatics: an integrated scenario.

Authors:  Namrata Tomar; Rajat K De
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

2.  Common features of mucosal and peripheral antibody responses elicited by candidate HIV-1 vaccines in rhesus monkeys.

Authors:  Hualin Li; Kathryn E Stephenson; Zi Han Kang; Christy L Lavine; Michael S Seaman; Dan H Barouch
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

3.  Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development.

Authors:  Kathryn E Stephenson; George H Neubauer; Ulf Reimer; Nikolaus Pawlowski; Tobias Knaute; Johannes Zerweck; Bette T Korber; Dan H Barouch
Journal:  J Immunol Methods       Date:  2014-11-15       Impact factor: 2.303

Review 4.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 5.  High throughput T epitope mapping and vaccine development.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Paolo Moretti; Fabrizio Manca
Journal:  J Biomed Biotechnol       Date:  2010-06-15

6.  A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling.

Authors:  Greg C Imholte; Renan Sauteraud; Bette Korber; Robert T Bailer; Ellen T Turk; Xiaoying Shen; Georgia D Tomaras; John R Mascola; Richard A Koup; David C Montefiori; Raphael Gottardo
Journal:  J Immunol Methods       Date:  2013-06-13       Impact factor: 2.303

7.  Bayesian hierarchical modeling for subject-level response classification in peptide microarray immunoassays.

Authors:  Gregory Imholte; Raphael Gottardo
Journal:  Biometrics       Date:  2016-04-08       Impact factor: 2.571

8.  Peptide microarrays to interrogate the "histone code".

Authors:  Scott B Rothbart; Krzysztof Krajewski; Brian D Strahl; Stephen M Fuchs
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

9.  Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.

Authors:  Simani Gaseitsiwe; Davide Valentini; Shahnaz Mahdavifar; Marie Reilly; Anneka Ehrnst; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

10.  Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip.

Authors:  Simani Gaseitsiwe; Davide Valentini; Raija Ahmed; Shahnaz Mahdavifar; Isabelle Magalhaes; Johannes Zerweck; Mike Schutkowski; Emmanuel Gautherot; Felix Montero; Anneka Ehrnst; Marie Reilly; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2009-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.